Selected research
Industry Growth & Trends
Global Drug Safety and Pharmacovigilance Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Drug Safety and Pharmacovigilance Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Drug Safety and Pharmacovigilance Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Drug Safety and Pharmacovigilance Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Drug Safety and Pharmacovigilance Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Drug Safety and Pharmacovigilance Service market include BioPoint, Cmed, Drug Safety Solutions, Hilbrans, Orbis Clinical, Parexel, PharmaLex, ProPharma and SGS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Drug Safety and Pharmacovigilance Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Drug Safety and Pharmacovigilance Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug Safety and Pharmacovigilance Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug Safety and Pharmacovigilance Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Drug Safety and Pharmacovigilance Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Drug Safety and Pharmacovigilance Service Market by Company
BioPoint
Cmed
Drug Safety Solutions
Hilbrans
Orbis Clinical
Parexel
PharmaLex
ProPharma
SGS
SJ Pharma Consulting LLC
Vitrana
X7 Research
Drug Safety and Pharmacovigilance Service Segment by Type
Drug Safety Service
Drug Pharmacovigilance Service
Drug Safety and Pharmacovigilance Service Segment by Application
Experimental Stage
Clinical Stage
Postmarketing Stage
Other
Drug Safety and Pharmacovigilance Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Safety and Pharmacovigilance Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Safety and Pharmacovigilance Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Safety and Pharmacovigilance Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Drug Safety and Pharmacovigilance Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Drug Safety Service
- Drug Pharmacovigilance Service
Applications
- Experimental Stage
- Clinical Stage
- Postmarketing Stage
- Other
Companies covered
- BioPoint
- Cmed
- Drug Safety Solutions
- Hilbrans
- Orbis Clinical
- Parexel
- PharmaLex
- ProPharma
- SGS
- SJ Pharma Consulting LLC
- Vitrana
- X7 Research
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Drug Safety and Pharmacovigilance Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Drug Safety and Pharmacovigilance Service Market Size by Region (2021-2032)
- 1.4.1 Global Drug Safety and Pharmacovigilance Service Market Size by Region (2021-2026)
- 1.4.2 Global Drug Safety and Pharmacovigilance Service Market Size by Region (2027-2032)
- 1.5 Key Regions Drug Safety and Pharmacovigilance Service Market Size (2021-2032)
- 1.5.1 North America Drug Safety and Pharmacovigilance Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Drug Safety and Pharmacovigilance Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Drug Safety and Pharmacovigilance Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Growth Rate (2021-2032)
2 Drug Safety and Pharmacovigilance Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Drug Safety Service
- 2.1.2 Drug Pharmacovigilance Service
- 2.2 Global Drug Safety and Pharmacovigilance Service Market Size by Type
- 2.2.1 Global Drug Safety and Pharmacovigilance Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Drug Safety and Pharmacovigilance Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Drug Safety and Pharmacovigilance Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Drug Safety and Pharmacovigilance Service Market Size by Regions
- 2.3.1 North America Drug Safety and Pharmacovigilance Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Drug Safety and Pharmacovigilance Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Drug Safety and Pharmacovigilance Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Drug Safety and Pharmacovigilance Service Market Size Breakdown by Type (2021-2026)
3 Drug Safety and Pharmacovigilance Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Experimental Stage
- 3.1.2 Clinical Stage
- 3.1.3 Postmarketing Stage
- 3.1.4 Other
- 3.2 Global Drug Safety and Pharmacovigilance Service Market Size by Application
- 3.2.1 Global Drug Safety and Pharmacovigilance Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Drug Safety and Pharmacovigilance Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Drug Safety and Pharmacovigilance Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Drug Safety and Pharmacovigilance Service Market Size by Regions
- 3.3.1 North America Drug Safety and Pharmacovigilance Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Drug Safety and Pharmacovigilance Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Drug Safety and Pharmacovigilance Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Drug Safety and Pharmacovigilance Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Drug Safety and Pharmacovigilance Service Industry Trends
- 4.2 Drug Safety and Pharmacovigilance Service Industry Drivers
- 4.3 Drug Safety and Pharmacovigilance Service Industry Opportunities and Challenges
- 4.4 Drug Safety and Pharmacovigilance Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Drug Safety and Pharmacovigilance Service Revenue (2021-2026)
- 5.2 Global Drug Safety and Pharmacovigilance Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Drug Safety and Pharmacovigilance Service Key Company Headquarters & Area Served
- 5.4 Global Drug Safety and Pharmacovigilance Service Company, Product Type & Application
- 5.5 Global Drug Safety and Pharmacovigilance Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Drug Safety and Pharmacovigilance Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Drug Safety and Pharmacovigilance Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Drug Safety and Pharmacovigilance Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 BioPoint
- 6.1.1 BioPoint Company Information
- 6.1.2 BioPoint Business Overview
- 6.1.3 BioPoint Drug Safety and Pharmacovigilance Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 BioPoint Drug Safety and Pharmacovigilance Service Product Portfolio
- 6.1.5 BioPoint Recent Developments
- 6.2 Cmed
- 6.2.1 Cmed Company Information
- 6.2.2 Cmed Business Overview
- 6.2.3 Cmed Drug Safety and Pharmacovigilance Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Cmed Drug Safety and Pharmacovigilance Service Product Portfolio
- 6.2.5 Cmed Recent Developments
- 6.3 Drug Safety Solutions
- 6.3.1 Drug Safety Solutions Company Information
- 6.3.2 Drug Safety Solutions Business Overview
- 6.3.3 Drug Safety Solutions Drug Safety and Pharmacovigilance Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Drug Safety Solutions Drug Safety and Pharmacovigilance Service Product Portfolio
- 6.3.5 Drug Safety Solutions Recent Developments
- 6.4 Hilbrans
- 6.4.1 Hilbrans Company Information
- 6.4.2 Hilbrans Business Overview
- 6.4.3 Hilbrans Drug Safety and Pharmacovigilance Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Hilbrans Drug Safety and Pharmacovigilance Service Product Portfolio
- 6.4.5 Hilbrans Recent Developments
- 6.5 Orbis Clinical
- 6.5.1 Orbis Clinical Company Information
- 6.5.2 Orbis Clinical Business Overview
- 6.5.3 Orbis Clinical Drug Safety and Pharmacovigilance Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Orbis Clinical Drug Safety and Pharmacovigilance Service Product Portfolio
- 6.5.5 Orbis Clinical Recent Developments
- 6.6 Parexel
- 6.6.1 Parexel Company Information
- 6.6.2 Parexel Business Overview
- 6.6.3 Parexel Drug Safety and Pharmacovigilance Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Parexel Drug Safety and Pharmacovigilance Service Product Portfolio
- 6.6.5 Parexel Recent Developments
- 6.7 PharmaLex
- 6.7.1 PharmaLex Company Information
- 6.7.2 PharmaLex Business Overview
- 6.7.3 PharmaLex Drug Safety and Pharmacovigilance Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 PharmaLex Drug Safety and Pharmacovigilance Service Product Portfolio
- 6.7.5 PharmaLex Recent Developments
- 6.8 ProPharma
- 6.8.1 ProPharma Company Information
- 6.8.2 ProPharma Business Overview
- 6.8.3 ProPharma Drug Safety and Pharmacovigilance Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 ProPharma Drug Safety and Pharmacovigilance Service Product Portfolio
- 6.8.5 ProPharma Recent Developments
- 6.9 SGS
- 6.9.1 SGS Company Information
- 6.9.2 SGS Business Overview
- 6.9.3 SGS Drug Safety and Pharmacovigilance Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 SGS Drug Safety and Pharmacovigilance Service Product Portfolio
- 6.9.5 SGS Recent Developments
- 6.10 SJ Pharma Consulting LLC
- 6.10.1 SJ Pharma Consulting LLC Company Information
- 6.10.2 SJ Pharma Consulting LLC Business Overview
- 6.10.3 SJ Pharma Consulting LLC Drug Safety and Pharmacovigilance Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 SJ Pharma Consulting LLC Drug Safety and Pharmacovigilance Service Product Portfolio
- 6.10.5 SJ Pharma Consulting LLC Recent Developments
- 6.11 Vitrana
- 6.11.1 Vitrana Company Information
- 6.11.2 Vitrana Business Overview
- 6.11.3 Vitrana Drug Safety and Pharmacovigilance Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Vitrana Drug Safety and Pharmacovigilance Service Product Portfolio
- 6.11.5 Vitrana Recent Developments
- 6.12 X7 Research
- 6.12.1 X7 Research Company Information
- 6.12.2 X7 Research Business Overview
- 6.12.3 X7 Research Drug Safety and Pharmacovigilance Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 X7 Research Drug Safety and Pharmacovigilance Service Product Portfolio
- 6.12.5 X7 Research Recent Developments
7 North America
- 7.1 North America Drug Safety and Pharmacovigilance Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Drug Safety and Pharmacovigilance Service Market Size by Country (2021-2026)
- 7.3 North America Drug Safety and Pharmacovigilance Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Drug Safety and Pharmacovigilance Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Drug Safety and Pharmacovigilance Service Market Size by Country (2021-2026)
- 8.3 Europe Drug Safety and Pharmacovigilance Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Drug Safety and Pharmacovigilance Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Drug Safety and Pharmacovigilance Service Market Size by Country (2021-2026)
- 10.3 South America Drug Safety and Pharmacovigilance Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst